Profile
- Research in clinical PET imaging with emphasis on total-body PET in the context of oncological, neurological, and cardiovascular diseases (early diagnosis, differential diagnosis).
- Preclinical and GMP-related radiopharmacy, biomedical engineering, instrumentation, dosimetry, artificial intelligence, and preclinical PET imaging.
- Further expand the therapeutic spectrum in Nuclear Medicine with the advent of novel radioligand therapies.
- Teaching students in the fields of medicine, biomedical engineering, and radiochemistry. Education of NM technologists.
External Partners
Dept. of Nuclear Medicine, Technical University Munich; Dept. of Nuclear Medicine, Ludwig-Maximilian-University Munich; Fudan University Shanghai, China; Institute of Nuclear Chemistry, Johannes Gutenberg-University Mainz; MGH AI Center, Harvard Medical School, USA; Dept. of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, China; Dept. of Molecular Pharmacology, UCLA, USA; School of Medical Technology, Peking University, Beijing, China; Dept. of Nuclear Medicine, Shanghai Jiaotong University, China; PET Center at UC Davis, USA; Dept. Nuclear Medicine, Seoul National University Hospital; Department of Experimental Particle Physics and Applications, Jagiellonian University, Poland
Grants
- Swiss National Science Foundations (grant no. 200021_188914; IZKSW3_188350; 310030_192704; 200021E_216944 / 1)
- Foundation for Clinical and Experimental Tumor Research
- Eureka (Innosuisse) (4842)
- SBFI (grant no. 101073231)
- Parkinson Schweiz
- Sinergia (CRSII-222763)